Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
André R Belisário, Ariadna AS da Silva, Cristiane VM Silva, Larissa MG de Souza, Eduarda A Wakabayashi, Stanley de A Araújo & Ana C Simoes-e-Silva. (2019) Sickle Cell Disease Nephropathy: An Update on Risk Factors and Potential Biomarkers in Pediatric Patients. Biomarkers in Medicine 13:11, pages 965-985.
Read now
Read now
Articles from other publishers (29)
Temitope Ajibawo & Oluwatimilehin Okunowo. (2024) Chronic kidney disease and outcomes in hospitalized sickle cell disease patients: A National Inpatient Sample analysis. European Journal of Haematology.
Crossref
Crossref
Muzamil Olamide Hassan, Fatiu Abiola Arogundade, Stephen Adebayo Osasan, Babajide A. Gbadegesin, Bolanle Aderonke Omotoso, Oluyomi Oluseun Okunola, Abubakr Abefe Sanusi, Kayode A. Adelusola, Norah O. Akinola & Adewale Akinsola. (2024) Clinicopathologic Study of Sickle Cell-associated Kidney Disease: A Nigerian Experience. Nigerian Postgraduate Medical Journal 31:1, pages 53-61.
Crossref
Crossref
Liping Xiao, Kai Clarke & Marja M Hurley. (2023) Fibroblast Growth Factor 23 Neutralizing Antibody Ameliorates Abnormal Renal Phosphate Handling in Sickle Cell Disease Mice. Endocrinology 164:12.
Crossref
Crossref
Lori‐Ann Fisher & Monika Asnani. (2023) Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID‐19 infection. eJHaem 4:1, pages 37-44.
Crossref
Crossref
William B. Ershler, Laura M. De Castro, Zahra Pakbaz, Aaron Moynahan, Derek Weycker, Thomas E. Delea, Irene Agodoa & Ze Cong. (2023) Hemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease. Current Therapeutic Research 98, pages 100696.
Crossref
Crossref
Samit Ghosh. 2022. Sickle Cell Disease. Sickle Cell Disease.
Jagadish Rao Padubidri, Amanda Christina Pinto, Jyoti R Kini, Hema Kini, Matthew Antony Manoj & Tanya Singh. (2022) Heat exertion precipitating shock and death in a case of previously undiagnosed sickle-cell disease. Medico-Legal Journal, pages 002581722211145.
Crossref
Crossref
Awni Alshurafa & Mohamed A. Yassin. (2022) Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease. Frontiers in Medicine 9.
Crossref
Crossref
Zachary Baldwin, Boshen Jiao, Anirban Basu, Joshua Roth, M. A. Bender, Zizi Elsisi, Kate M. Johnson, Emma Cousin, Scott D. Ramsey & Beth Devine. (2022) Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis. PharmacoEconomics - Open 6:4, pages 469-481.
Crossref
Crossref
Kenneth I. Ataga, Santosh L. Saraf & Vimal K. Derebail. (2022) The nephropathy of sickle cell trait and sickle cell disease. Nature Reviews Nephrology 18:6, pages 361-377.
Crossref
Crossref
Osama Y Safdar, Rana M Baghdadi, Sereen A Alahmadi, Bana E Fakieh & Amaal M Algaydi. (2022) Sickle cell nephropathy: A review of novel biomarkers and their potential roles in early detection of renal involvement. World Journal of Clinical Pediatrics 11:1, pages 14-26.
Crossref
Crossref
Thomas Graf, Connie Piccone & Katherine MacRae Dell. 2022. Pediatric Nephrology. Pediatric Nephrology
735
749
.
Deepali K. Bhat, Purevdorj B. Olkhanud, Arunakumar Gangaplara, Fayaz Seifuddin, Mehdi Pirooznia, Angélique Biancotto, Giovanna Fantoni, Corinne Pittman, Berline Francis, Pradeep K. Dagur, Ankit Saxena, J. Philip McCoy, Ruth M. Pfeiffer & Courtney D. Fitzhugh. (2021) Early Myeloid Derived Suppressor Cells (eMDSCs) Are Associated With High Donor Myeloid Chimerism Following Haploidentical HSCT for Sickle Cell Disease. Frontiers in Immunology 12.
Crossref
Crossref
Boris Tchernychev, Huihui Li, Sung‐Kyun Lee, Xin Gao, Raghunath Ramanarasimhaiah, Guang Liu, Katherine C. Hall, Sylvie G. Bernier, Juli E. Jones, Susanne Feil, Robert Feil, Emmanuel S. Buys, Regina M. Graul, Paul S. Frenette & Jaime L. Masferrer. (2021) Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso‐occlusion and nephropathy in mouse models of sickle cell disease. British Journal of Pharmacology 178:17, pages 3463-3475.
Crossref
Crossref
Kunjan Udani, Nayda Parisio-Poldiak, Julia Campbell, Victor Collier & Pooja Patel. (2021) All-Cause Mortality and Incidence of Major Adverse Cardiac Events in Sickle Cell Nephropathy: A Comparative Study. Cureus.
Crossref
Crossref
Richard A. Preston, Thomas Marbury, Ganesh Balaratnam, Michelle Green, Sandy Dixon, Josh Lehrer‐Graiwer & Carla Washington. (2020) Pharmacokinetics of Voxelotor in Patients With Renal and Hepatic Impairment. The Journal of Clinical Pharmacology 61:4, pages 493-505.
Crossref
Crossref
Lakshmanan Krishnamurti. (2021) Hematopoietic Cell Transplantation for Sickle Cell Disease. Frontiers in Pediatrics 8.
Crossref
Crossref
Thomas Graf, Connie Piccone & Katherine MacRae Dell. 2020. Pediatric Nephrology. Pediatric Nephrology
1
15
.
Brinda K. Tammara, Kelly Ryan, Anna Plotka, Frank E. Shafer, Hua Wei, David Readett, Annie Fang & Joan M. Korth‐Bradley. (2020) Effect of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Intravenous Rivipansel. Clinical Pharmacology in Drug Development 9:8, pages 918-928.
Crossref
Crossref
Akram Mohammed, Pradeep S B Podila, Robert L Davis, Kenneth I Ataga, Jane S Hankins & Rishikesan Kamaleswaran. (2020) Using Machine Learning to Predict Early Onset Acute Organ Failure in Critically Ill Intensive Care Unit Patients With Sickle Cell Disease: Retrospective Study. Journal of Medical Internet Research 22:5, pages e14693.
Crossref
Crossref
Meghan McCormick, Troy Richardson, Bradley A. Warady, Enrico M. Novelli & Ramasubramanian Kalpatthi. (2020) Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization. British Journal of Haematology 189:3, pages 559-565.
Crossref
Crossref
Omar Niss, Adam LaneMonika R. Asnani, Marianne E. Yee, Ashok RajSusan CrearyCourtney FitzhughPrasad BodasSantosh L. Saraf, Sharada Sarnaik, Prasad Devarajan & Punam Malik. (2020) Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study. Blood Advances 4:7, pages 1501-1511.
Crossref
Crossref
Malgorzata Kasztan, Inmaculada Aban, Suraj P. Hande, David M. Pollock & Jeffrey D. Lebensburger. (2020) Sex differences in the trajectory of glomerular filtration rate in pediatric and murine sickle cell anemia. Blood Advances 4:2, pages 263-265.
Crossref
Crossref
Marília Rocha Laurentino, Sérgio Luiz Arruda Parente Filho, Lívia Leal Chagas Parente, Geraldo Bezerra da Silva Júnior, Elizabeth De Francesco Daher & Romélia Pinheiro Gonçalves Lemes. (2019) Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview. Annals of Hematology 98:12, pages 2653-2660.
Crossref
Crossref
Elizabeth O. Stenger, Shalini Shenoy & Lakshmanan Krishnamurti. (2019) How I treat sickle cell disease with hematopoietic cell transplantation. Blood.
Crossref
Crossref
Frank Park, Hitesh Soni, Jeffrey D. Pressly & Adebowale Adebiyi. (2019) Acute hydroxyurea treatment reduces tubular damage following bilateral ischemia-reperfusion injury in a mouse model of sickle cell disease. Biochemical and Biophysical Research Communications 515:1, pages 72-76.
Crossref
Crossref
Paula Tanabe, Regena Spratling, Dana Smith, Peyton Grissom & Mary Hulihan. (2019) CE: Understanding the Complications of Sickle Cell Disease. AJN, American Journal of Nursing 119:6, pages 26-35.
Crossref
Crossref
Courtney D. Fitzhugh & Mark C. Walters. (2017) The case for HLA-identical sibling hematopoietic stem cell transplantation in children with symptomatic sickle cell anemia. Blood Advances 1:26, pages 2563-2567.
Crossref
Crossref
Amin S. Banaga, Hala I. Elhardlu & Khalifa Elmusharaf. (2016) Renal Manifestations among Adult Sickle Cell Disease Patients: A Single Center Study in Khartoum, Sudan. Open Journal of Nephrology 06:04, pages 157-160.
Crossref
Crossref